Hepatitis B drug may offer 'functional cure' for some patients

AI Summary

Researchers reported Thursday that in two international studies, about 1 in 5 patients given the experimental drug for six months saw their virus reduced to levels low enough that the immune system could keep it in check. Newsiline summarises this report from PBS NewsHour Headlines and links readers to the original publisher for the full story.

Key Points

• Original report published by PBS NewsHour Headlines.
• Newsiline stores only headline metadata, source credit, and a short summary.
• Readers are directed to the publisher for the complete article.

Why It Matters

This story may affect readers following the category, country, or source involved. Newsiline keeps the summary neutral and points to the publisher for full context.